NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,471 | -55.9% | 11,858 | -46.0% | 0.00% | – |
| Q2 2023 | $84,916 | +27.7% | 21,942 | -8.6% | 0.00% | – |
| Q1 2023 | $66,480 | -50.4% | 24,000 | -61.9% | 0.00% | – |
| Q3 2022 | $134,000 | +44.1% | 63,062 | +82.0% | 0.00% | – |
| Q2 2022 | $93,000 | -78.3% | 34,650 | -65.0% | 0.00% | – |
| Q1 2022 | $429,000 | +14.1% | 98,865 | +35.9% | 0.00% | – |
| Q4 2021 | $376,000 | -39.3% | 72,738 | -27.9% | 0.00% | – |
| Q3 2021 | $619,000 | +291.8% | 100,892 | +546.7% | 0.00% | – |
| Q2 2021 | $158,000 | – | 15,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $19,026 | 6.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $4,284,679 | 4.48% |
| ArchPoint Investors | 1,449,551 | $4,580,581 | 1.75% |
| Tikvah Management LLC | 1,313,895 | $4,151,908 | 1.49% |
| Perceptive Advisors | 9,111,151 | $28,791,237 | 0.96% |
| Cercano Management LLC | 7,172,985 | $22,666,633 | 0.81% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $6,320,000 | 0.71% |
| HILLMAN CO | 200,000 | $632,000 | 0.38% |
| Comprehensive Financial Management LLC | 2,207,619 | $6,976,076 | 0.25% |
| Clarius Group, LLC | 597,769 | $1,888,950 | 0.18% |